Wolverine Trading
CRBP icon

Wolverine Trading’s Corbus Pharmaceuticals CRBP Stock Holding History

Wolverine Trading’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-907
Closed -$7K – 4694
2022
Q2 		$7K Sell
907
-656
-42% -$6.34K ﹤0.01% 4331
2022
Q1 		$24K Buy
1,563
+790
+102% +$10.5K ﹤0.01% 5220
2021
Q4 		$14K Sell
773
-327
-30% -$8.86K ﹤0.01% 5531
2021
Q3 		$33K Sell
1,100
-150
-12% -$5.92K ﹤0.01% 6080
2021
Q2 		$69K Sell
1,250
-887
-42% -$49.2K ﹤0.01% 5537
2021
Q1 		$119K Sell
2,137
-36
-2% -$2.37K ﹤0.01% 5362
2020
Q4 		$83K Sell
2,173
-1,764
-45% -$65.9K ﹤0.01% 4513
2020
Q3 		$233K Buy
3,937
+2,957
+302% +$536K ﹤0.01% 3694
2020
Q2 		$233K Buy
980
+157
+19% +$31.7K ﹤0.01% 3646
2020
Q1 		$136K Buy
823
+386
+88% +$65.3K ﹤0.01% 3874
2019
Q4 		$70K Sell
437
-1,033
-70% -$153K ﹤0.01% 4378
2019
Q3 		$221K Buy
1,470
+103
+8% +$17.9K ﹤0.01% 3471
2019
Q2 		$284K Sell
1,367
-140
-9% -$30K ﹤0.01% 3326
2019
Q1 		$314K Buy
1,507
+1,014
+206% +$224K ﹤0.01% 3312
2018
Q4 		$87K Sell
493
-537
-52% -$107K ﹤0.01% 4024
2018
Q3 		$233K Sell
1,030
-223
-18% -$36.1K ﹤0.01% 4054
2018
Q2 		$229K Hold
1,253
– – ﹤0.01% 4190
2018
Q1 		$229K Buy
+1,253
New +$281K ﹤0.01% 4190
2017
Q3 		– Sell
-660
Closed -$124K – 4488
2017
Q2 		$124K Buy
+660
New +$129K ﹤0.01% 3826

Other funds holding CRBP

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wolverine Trading's CRBP Position: Q2 2022 in Review

Wolverine Trading sold out of Corbus Pharmaceuticals (CRBP) in Q2 2022, closing a stake of 613 shares — an estimated $5.92K sold.

Wolverine Trading first reported a position in CRBP in Q2 2017 and held it in 14 quarters. The position peaked at $201K in Q4 2018. 70 funds tracked by Wall St. Rank hold CRBP as of Q2 2022.

  • Wolverine Trading reported no remaining Corbus Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Wolverine Trading sold 613 Corbus Pharmaceuticals shares in Q2 2022, an estimated $5.92K.
  • Wolverine Trading first reported a position in Corbus Pharmaceuticals in Q2 2017 and held it in 14 quarters.
  • Wolverine Trading's Corbus Pharmaceuticals position peaked at $201K in Q4 2018.
  • 70 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2022.

Based on Wolverine Trading's 13F filing for Q2 2022, filed 15 Aug 2022.